Welcome to our dedicated page for Celanese Del SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Celanese Corporation (NYSE: CE) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including Form 8-K current reports and other documents filed with the U.S. Securities and Exchange Commission. Celanese is a global specialty materials and chemical company in the basic organic chemical manufacturing industry, and its filings offer detailed insight into its financing activities, governance developments and operational decisions.
Recent Form 8-K filings describe a range of material events. Several filings outline registered offerings of senior notes by Celanese US Holdings LLC, a wholly owned subsidiary, including 7.000% Senior Notes due 2031 and 7.375% Senior Notes due 2034. These filings explain that net proceeds are used to repay borrowings under a five-year term loan credit agreement due 2027, fund cash tender offers for outstanding senior notes due 2027 and 2028, and support general corporate purposes, which may include repayment of other indebtedness.
Other 8-K reports cover cash tender offers for the company’s 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028, including announcements of the commencement of tender offers, early results and increases in the maximum tender amount and series cap. Additional filings detail a revolving credit agreement providing a five-year unsecured revolving credit facility and an amendment to an existing term loan credit agreement, including new covenant terms.
Celanese filings also document operational and portfolio actions, such as the intended closure of an acetate tow production facility in Lanaken, Belgium, with associated expected non-cash accelerated depreciation and other shutdown costs, and the signing of a purchase and sale agreement to divest the Micromax® portfolio of products. Governance-related filings include the resignation of a Board member and the company’s explanation that the departure was not due to any disagreement on operations, policies or practices.
On Stock Titan, these SEC filings are presented with real-time updates from EDGAR and AI-powered summaries that help explain the key points of each document. Users can quickly understand the implications of Celanese’s 8-K disclosures, senior note offerings, credit agreements, tender offers and other reported events without reading every technical detail.
Celanese Corporation is asking shareholders to vote on key governance and compensation items at its 2026 virtual annual meeting. Shareholders will elect nine directors to one-year terms, ratify KPMG LLP as independent auditor for 2026, and cast an advisory vote on executive compensation.
The proxy highlights an actively refreshed, largely independent Board, with 8 of 9 nominees independent and an independent Chair. It emphasizes strong governance features such as annual director elections, majority voting, proxy access, no supermajority provisions and no poison pill, plus robust shareholder engagement.
Celanese reports 2025 net sales of $9,544 million, a GAAP diluted loss per share of $(10.44), adjusted EPS of $3.98, a net loss of $1,165 million, operating EBITDA of $1,893 million, operating cash flow of $1,146 million and free cash flow of $773 million, and frames these results within a strategy focused on free cash flow, deleveraging, portfolio optimization and long-term value creation.
Celanese Corporation reported that on February 27, 2026, Timothy Go resigned from its Board of Directors, effective the same day. The company states that his resignation was not due to any disagreement regarding operations, policies, or practices. The Board and the company expressed appreciation for his service as a director.
Richardson Scott A reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp CEO Scott A. Richardson reported equity awards on February 27, 2026. He was granted 70,663 nonqualified stock options and 50,623 time-based restricted stock units under the company’s 2018 Global Incentive Plan, vesting in installments from February 15, 2027 through February 15, 2029. He also reports 595.4436 common shares held indirectly through a 401(k) plan.
Murray Mark Christopher reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president Mark Christopher Murray received new equity awards. On February 27, 2026, he was granted 14,561 nonqualified stock options with time-based vesting and 10,431 shares of common stock in the form of restricted stock units under the company’s 2018 Global Incentive Plan. The options and RSUs vest in three annual tranches from February 15, 2027 through February 15, 2029, subject to continued employment.
McGilvray Aaron M reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp Chief Accounting Officer Aaron M. McGilvray received new equity awards. He was granted nonqualified stock options for 2,355 shares and time-based restricted stock units covering 1,687 shares of common stock at no cost.
The RSUs vest 33% on February 15, 2027 and 2028, and 34% on February 15, 2029, if employment continues. The options vest in three annual installments of 33%, 33%, and 34% beginning February 15, 2027. He also reports indirect holdings through a 401(k) plan.
Celanese Corp reported that its SVP & CFO, Chuck Kyrish, received an equity compensation grant. He acquired 15,678 time-based restricted stock units, each convertible into one share of common stock under the company’s Amended and Restated 2018 Global Incentive Plan.
Kyrish was also granted 21,884 time-based nonqualified stock options under the same plan. The RSUs vest in portions of 33%, 33%, and 34% on February 15 of 2027, 2028, and 2029, while the options vest in three annual installments of 33%, 33%, and 34% beginning February 15, 2027, all subject to continued employment.
Elliott Todd L reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president Todd L. Elliott reported equity awards that increase his direct holdings. On February 27, 2026, he received 17,558 nonqualified stock options and 12,579 time-based restricted stock units (RSUs) at no cash cost.
The RSUs, each representing one future share of common stock, vest with 33% on February 15, 2027, 33% on February 15, 2028, and 34% on February 15, 2029, subject to continued employment. The stock options vest on the same 33%, 33%, 34% annual schedule beginning February 15, 2027.
Duffie Ashley B reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president and general counsel Ashley B. Duffie reported equity awards that increase her stake in the company. She received a grant of 14,561 nonqualified stock options and 10,431 shares of common stock, both awarded at a stated price of
The options are time-based employee stock options granted under the company’s Amended and Restated 2018 Global Incentive Plan and vest in three installments of
Celanese Corporation files its Form 10-K describing a diversified global chemicals and engineered materials business with 51 production sites, 20 affiliate facilities and 11,434 employees as of December 31, 2025. The company operates through two main segments: Engineered Materials and the Acetyl Chain.
Engineered Materials supplies high‑performance polymers for automotive, medical, electronics and industrial uses, while the Acetyl Chain provides key intermediates like acetic acid, VAM, emulsions and EVA used in coatings, adhesives, packaging and construction. Strategic affiliates generated $1.9 billion of sales in 2025, contributing $78 million of equity earnings and $95 million of dividends.
Management reports a strong safety record, with a 2025 Total Recordable Incident Rate of 0.10 and Lost Time Incident Rate of 0.03. The filing highlights climate and sustainability initiatives, including carbon capture methanol, renewable energy projects and low‑carbon product lines, alongside an announced Scope 1 and 2 emissions reduction target disclosed in the 2024‑2025 Sustainability Report.
Financially, Celanese recorded a noncash goodwill impairment of $1.1 billion and $346 million of trade name impairments in Engineered Materials, and expects about $140 million of charges through 2027 from closing its Lanaken, Belgium facility. As part of deleveraging, the quarterly dividend was reduced by roughly 95% beginning in early 2025.